1.1651
05-十一月-24 12:32:35
15 分钟延时
股票
-0.0049
-0.42%
今日范围
1.1401 - 1.1900
ISIN
N/A
来源
NASDAQ
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences
23 10月 2024 07:00:01 条件 Nasdaq GlobeNewswire
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
22 10月 2024 07:00:01 条件 Nasdaq GlobeNewswire
Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
15 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire